Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy |
Jeong, Ju-Hyeon
(Asan Medical Center)
Nho, Ju-Hee (Department of Nursing, University of Ulsan) Kim, Gi-Suk (Asan Medical Center) Lee, Young-Eun (Asan Medical Center) Yu, Sun-Young (Asan Medical Center) Lee, Hyun-Ju (Asan Medical Center) Sim, Yu-Mi (Asan Medical Center) Lee, Young-Sun (Asan Medical Center) |
1 | Bakitas, M. A. (2007). Background noise: The experience of chemotherapy- induced peripheral neuropathy. Nursing Research, 56, 323-331. http://dx.doi.org/10.1097/01.nnr.0000 289503.22414.79 DOI |
2 | Bartlett, J. E., Kotrlik, J. W., & Higgins, C. C. (2001). Organizational research: Determining appropriate sample size in survey research. Information Technology, Learning, and Performance Journal, 19, 43-50. |
3 | Berek, J. S. (2007). Berek & Novak's Gynecology (14ed.). Philadelphia: Lippincott. |
4 | Calhoun, E. A., Welshman, E. E., Chang, C. H., Lurain, J. R., Fishman, D. A., Hunt, T. L., et al. (2003). Psychometric evaluation of functional assessment of cancer therapy/gynecologic oncology group-neurotoxicity(FACT/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. International Journal of Gynecologic Oncology, 13, 741-748. DOI ScienceOn |
5 | Cella, D. (1997). Manual of the functional assessment of chronic illness therapy (FACIT) measurement system. Evanston, IL: Center on outcomes, research and education (CORE), Evanston Northwestern Healthcare and Northwestern University. |
6 | Hausheer, F. H., Schilsky, R. L., Bain, S., Berghorn, E. J., & Lieberman, F. (2006). Diagnosis, management, and evaluation of chemotherapy induced peripheral neuropathy. Seminars in Oncology, 33, 15-49. |
7 | Kaley, T. J., & Deangelis, L. M. (2009). Therapy of chemotherapyinduced peripheral neuropathy. British Journal of Haematology, 145, 3-14. http://dx.doi.org/10.1111/j.1365-2141.2008. 07558.x DOI ScienceOn |
8 | Kim, H. M. (2012). Symptoms and relief therapy related to chemotherapy induced peripheral neuropathy in patients with cancer. Unpublished master's thesis, Keimyoung University, Daegu. |
9 | Kim, J. H., Choi, K. S., Kim, T. W., & Hong, Y. S. (2011). Quality of life in colorectal cancer patients with chemotherapy induced peripheral neuropathy. Journal of Korean Oncology Nursing, 11, 254-262. http://dx.doi.org/10.5388/jkon.2011. 11.3.254 DOI |
10 | Kiser, D. W., Greer, T. B., Wilmoth, M. C., Dmochowski, J., & Naumann, R. W. (2010). Peripheral neuropathy in patients with gynecologic cancer receiving chemotherapy: Patient reports and provider assessments. Oncology Nursing Forum, 37, 758-764. http://dx.doi.org/10.1188/10.ONF.758-764 DOI ScienceOn |
11 | Kwak, M. K., Kim, E. J., Lee, E. R., Kwon, I. G., & Hwang, M. S. (2010). Characteristics and quality of life in patients with chemotherapy induced peripheral neuropathy. Journal of Korean Oncology Nursing, 10, 231-239. DOI |
12 | Long, H. J., Monk, B. J., Huang, H. Q., Grendys, E. C., Mc- Meekin, D. S., Sorosky, J., et al. (2006). Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A gynecologic oncology group study. Gynecologic Oncology, 100, 537-543. DOI ScienceOn |
13 | Mantyh, P. W. (2006). Cancer pain and its impact on diagnosis, survival and quality of life. Nature Reviews Neuroscience, 7, 797-809. DOI ScienceOn |
14 | Smith, E. L., Whedon, M. B., & Bookbinder, M. (2002). Quality improvement of painful peripheral neuropathy. Seminars in Oncology Nursing, 18, 36-43. DOI ScienceOn |
15 | Pan, Y., & Kao, M. S. (2007). Discordance of clinical symptoms and electrophysiologic findings in taxane plus platinum-induced neuropathy. International Journal of Gynecological Cancer, 17, 394-397. http://dx.doi.org/10.1111/j.1525-1438. 2006.00766.x DOI ScienceOn |
16 | Park, A. R., Kim, S. J., Bang, J. S., & La, H. O. (2009). Oxaliplatininduced peripheral neuropathy in patients with advanced or metastatic gastric cancer. The Korean Journal of Clinical Pharmacy, 19, 18-22. |
17 | Rao, R. D., Michalak, J. C., Sloan, J. A., Loprinzi, C. L., Soori, G. S., Nikcevich, D. A., et al. (2007). Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled, cross-over trial. Cancer, 110, 2110-2118. http://dx. doi.org/10.1002/cncr.23008 DOI ScienceOn |
18 | Smith, E. M., Beck, S. L., & Cohen, J. (2008). The total neuropathy score: A tool for measuring chemotherapy-induced peripheral neuropathy. Oncology Nursing Forum, 35, 96-102. http://dx.doi.org/10.1188/08.ONF.96-102 DOI ScienceOn |
19 | Statistics Korea. (2010). Cancer occurrence ratio in Korea women. Retrieved July, 15, 2013, from http://kosis.kr/wnsearch/ totalSearch.jsp |
20 | Sweeney, C. W. (2002). Understanding peripheral neuropathy in patients with cancer: Background and patients assessment. Clinical Journal of Oncology Nursing, 6, 163-166. DOI ScienceOn |
21 | Tofthagen, C. (2010). Patient perceptions associated with chemotherapy- induced peripheral neuropathy. Clinical Journal of Oncology Nursing, 14, E22-E28. http://dx.doi.org/10.1188/ 10.CJON.E22-E28 DOI ScienceOn |
22 | Tofthagen, C., McAllister, R. D., & McMillan, S. C. (2011). Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin. Clinical Journal of Oncology Nursing, 15 , 182-188. http://dx.doi.org/10.1188/11.CJON.182-188 DOI ScienceOn |
23 | Wolf, S., Barton, D., Kottschade, L., Grothey, A., & Loprinzi, C. (2008). Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies. European Journal of Cancer, 44, 1507-1515. http://dx.doi.org/10.1016/j.ejca.2008. 04.018 DOI ScienceOn |
24 | Verstappen, C. C., Heimans, J. J., Hoekman, K., & Postma, T. J. (2003). Neurotoxic complication of chemotherapy in patients with cancer: Clinical signs and optimal management. Drugs, 63, 1549-1563. DOI ScienceOn |
25 | Viens, P., Petit, T., Yovine, A., Bougnoux, P., Deplanque, G., Cottu, P. H., et al. (2006). A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients. Annuals of Oncology, 17, 429- 436. http://dx.doi.org/10.1093/annonc/mdj097 DOI ScienceOn |
26 | Wickham, R. (2007). Chemotherapy-induced peripheral neuropathy: A review and implications for oncology nursing practice. Clinical Journal of Oncology Nursing, 11 , 361-376. DOI ScienceOn |
27 | Yarbro, C. H., Frogge, M. H., & Goodman, M. (2004). Cancer symptom management (3rd ed.). Boston: Jones and Bartlett. |